Ros Matthew 4
4 · Cogent Biosciences, Inc. · Filed Oct 3, 2023
Insider Transaction Report
Form 4
Ros Matthew
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-10-02+2,170→ 2,170 totalExercise: $9.55From: 2023-10-02Exp: 2033-10-02→ Common Stock (2,170 underlying)
Footnotes (1)
- [F1]The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.